Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Ocular Therapeutix Inc.

    NASDAQ: OCUL · Real-Time Price · USD
    9.24
    -0.22 (-2.33%)
    At close: Jun 27, 2025, 3:59 PM
    9.22
    -0.22%
    After-hours: Jun 27, 2025, 04:34 PM EDT

    Ocular Therapeutix Statistics

    Share Statistics

    Ocular Therapeutix has 159.3M shares outstanding. The number of shares has increased by 2.67% in one year.

    Shares Outstanding

    n/a
    		 159.3M

    Shares Change (YoY)

    n/a
    		 2.67%

    Shares Change (QoQ)

    n/a
    		 1.15%

    Owned by Institutions (%)

    n/a
    		 80.15%

    Shares Floating

    n/a
    		 133.64M

    Failed to Deliver (FTD) Shares

    n/a
    		 10,000

    FTD / Avg. Volume

    n/a
    		 0.48%

    Short Selling Information

    The latest short interest is 14.26M, so 8.95% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 14.26M

    Short % of Shares Out

    n/a
    		 8.95%

    Short % of Float

    n/a
    		 9%

    Short Ratio (days to cover)

    n/a
    		 8.21

    Valuation Ratios

    The PE ratio is -6.98 and the forward PE ratio is -6.58. Ocular Therapeutix's PEG ratio is -0.59.

    PE Ratio

    n/a
    		 -6.98

    Forward PE

    n/a
    		 -6.58

    PS Ratio

    n/a
    		 21.21

    Forward PS

    n/a
    		 2.1

    PB Ratio

    n/a
    		 4.29

    P/FCF Ratio

    n/a
    		 -9.94

    PEG Ratio

    n/a
    		 -0.59
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Ocular Therapeutix.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 10.66, with a Debt / Equity ratio of 0.24.

    Current Ratio

    n/a
    		 10.66

    Quick Ratio

    n/a
    		 10.59

    Debt / Equity

    n/a
    		 0.24

    Debt / EBITDA

    n/a
    		 -0.43

    Debt / FCF

    n/a
    		 -0.56

    Interest Coverage

    n/a
    		 -12.65

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $232,565.69

    Profits Per Employee

    n/a
    		 $-706,226.28

    Employee Count

    n/a
    		 274

    Asset Turnover

    n/a
    		 0.14

    Inventory Turnover

    n/a
    		 1.85

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 39.79% in the last 52 weeks. The beta is 1.41, so Ocular Therapeutix's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.41

    52-Week Price Change

    n/a
    		 39.79%

    50-Day Moving Average

    n/a
    		 7.99

    200-Day Moving Average

    n/a
    		 8.46

    Relative Strength Index (RSI)

    n/a
    		 66.7

    Average Volume (20 Days)

    n/a
    		 2,062,161

    Income Statement

    In the last 12 months, Ocular Therapeutix had revenue of 63.72M and earned -193.51M in profits. Earnings per share was -1.22.

    Revenue

    n/a
    		 63.72M

    Gross Profit

    n/a
    		 58.1M

    Operating Income

    n/a
    		 -171.78M

    Net Income

    n/a
    		 -193.51M

    EBITDA

    n/a
    		 -176.14M

    EBIT

    n/a
    		 -179.93M

    Earnings Per Share (EPS)

    n/a
    		 -1.22
    Full Income Statement

    Balance Sheet

    The company has 392.1M in cash and 75.78M in debt, giving a net cash position of 316.32M.

    Cash & Cash Equivalents

    n/a
    		 392.1M

    Total Debt

    n/a
    		 75.78M

    Net Cash

    n/a
    		 316.32M

    Retained Earnings

    n/a
    		 -891.08M

    Total Assets

    n/a
    		 405.92M

    Working Capital

    n/a
    		 349.77M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -134.68M and capital expenditures -1.29M, giving a free cash flow of -135.97M.

    Operating Cash Flow

    n/a
    		 -134.68M

    Capital Expenditures

    n/a
    		 -1.29M

    Free Cash Flow

    n/a
    		 -135.97M

    FCF Per Share

    n/a
    		 -0.86
    Full Cash Flow Statement

    Margins

    Gross margin is 91.17%, with operating and profit margins of -269.57% and -303.67%.

    Gross Margin

    n/a
    		 91.17%

    Operating Margin

    n/a
    		 -269.57%

    Pretax Margin

    n/a
    		 -303.67%

    Profit Margin

    n/a
    		 -303.67%

    EBITDA Margin

    n/a
    		 -276.42%

    EBIT Margin

    n/a
    		 -269.57%

    FCF Margin

    n/a
    		 -213.37%

    Dividends & Yields

    OCUL does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for OCUL is $17, which is 79.9% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $17

    Price Target Difference

    n/a
    		 79.9%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 7
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 1.93

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist